Open Orphan chief to underwrite part of £30m hVivo takeover
Friel ready to stump up €3m of fundraising for purchase of British clinical trials firm
Open Orphan chief executive Cathal Friel will underwrite about €3 million of the company’s planned fundraising as part of its £30 million takeover of British company hVivo.
Pharma services company Open Orphan is to launch a share placing early in the new year to raise as much as £10 million from investors to fund the takeover of the British company, which is involved in clinical trials. Friel is one of the largest investors...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month, €19.99 Monthly thereafter
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team
Malin shareholders in line for windfall after €119 million cash boost
Dublin-based biotech investment fund said €45 million of the proceeds from the sale will be used to repay a European Investment Bank loan, with the remaining cash to be returned to shareholders later this year
Amryt seeks to have rare condition drug approved for payment
The Dublin company is in discussion with regulators in Britain and France to have metreleptin, a treatment for abnormal distribution of fat in the body, approved for payment reimbursement